BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 15446551)

  • 1. [Soft tissue sarcoma: postoperative chemotherapy].
    Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
    Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy of soft tissue sarcoma].
    Shinohara N; Yokoyama K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years].
    Jürgens H; Bier V; Dunst J; Harms D; Jobke A; Kotz R; Kühl J; Müller-Weihrich S; Ritter J; Salzer-Kuntschik M
    Klin Padiatr; 1988; 200(3):243-52. PubMed ID: 3145357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of sarcomas in the adult].
    Rouëssé J; Tubiana-Hulin M
    Bull Cancer; 1988; 75(5):483-92. PubMed ID: 3165036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant chemotherapy in the treatment of sarcomas].
    Fayette J; Blay JY
    Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of sarcomas].
    Meuret G
    Dtsch Med Wochenschr; 1978 Feb; 103(7):308-13. PubMed ID: 342221
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
    Takeuchi S; Akahoshi Y; Kasai C; Nishimoto Y
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1113-22. PubMed ID: 6088833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
    Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P
    Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced sarcomas of bone and soft tissue.
    Antman KH
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
    Yonemoto T; Tatezaki S; Ishii T; Satoh T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.